BlackThorn Therapeutics

BlackThorn Therapeutics is a clinical-stage biopharmaceutical company dedicated to discovering and developing targeted therapies for central nervous system (CNS) disorders. Leveraging our computational psychiatry platform, Pathfinder™, our approach is based on the quantitative, brain-based understanding of neurobehavioral dysfunctions. These data-driven insights can be used to create treatment approaches tailored to patients based on biological subtypes, enhancing the precision of therapeutic interventions. Our clinical pipeline aims to restore balance to dysfunctional brain circuits and improve the lives of patients with CNS disorders.